{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:25:45Z","timestamp":1773285945668,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jviromet.2010.07.015","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T08:40:59Z","timestamp":1279874459000},"page":"259-268","source":"Crossref","is-referenced-by-count":17,"title":["Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles"],"prefix":"10.1016","volume":"169","author":[{"given":"Robert B.","family":"Mandell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Koukuntla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.K.","family":"Mogler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea K.","family":"Carzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Vahanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Flick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2010.07.015_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0882-4010(88)90096-4","article-title":"Viral determinants of virulence for Rift Valley fever (RVF) in rats","volume":"5","author":"Anderson","year":"1988","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1991.44.475","article-title":"Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance","volume":"44","author":"Anderson","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0882-4010(87)90126-4","article-title":"Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats","volume":"2","author":"Anderson","year":"1987","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0020","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"Bird","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2009.08.002","article-title":"Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines","author":"Bouloy","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0040","series-title":"Digital Image Processing: An Algorithmic Introduction Using Java","year":"2008"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0045","first-page":"229","article-title":"DIVA\u2014a vaccination strategy enabling the detection of field exposure to avian influenza","volume":"119","author":"Capua","year":"2004","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0050","series-title":"The Biology of Negative Strand Viruses","first-page":"321","article-title":"Protective subunit immunogens to Rift Valley fever virus from bacteria and recombinant vaccinia virus","author":"Collett","year":"1987"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0042-6822(85)90320-4","article-title":"Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus","volume":"144","author":"Collett","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0060","series-title":"Vaccines \u201889","first-page":"371","article-title":"Mapping protective determinants of Rift Valley fever virus using recombinant vaccinia viruses","author":"Dalrymple","year":"1989"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","author":"de Boer","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0070","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/156652405774962263","article-title":"Rift Valley fever virus","volume":"5","author":"Flick","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3201\/eid0402.980218","article-title":"New vectors of Rift Valley fever in West Africa","volume":"4","author":"Fontenille","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.copbio.2004.10.002","article-title":"Virus-like particles as vaccines and vessels for the delivery of small molecules","volume":"15","author":"Garcea","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0090","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.20506\/rst.23.2.1500","article-title":"Rift Valley fever","volume":"23","author":"Gerdes","year":"2004","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2008.12.011","article-title":"Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses","volume":"385","author":"Habjan","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-3527(06)68005-6","article-title":"Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce \u201cmammalianized\u201d recombinant glycoproteins","volume":"68","author":"Harrison","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/erv.09.8","article-title":"Influenza virus-like particle vaccines","volume":"8","author":"Haynes","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0120","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.178.4.2361","article-title":"Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN","volume":"178","author":"Hervas-Stubbs","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2004.10.018","article-title":"From gene to protein: a review of new and enabling technologies for multi-parallel protein expression","volume":"40","author":"Hunt","year":"2005","journal-title":"Protein Expr. Purif."},{"issue":"Suppl. 4","key":"10.1016\/j.jviromet.2010.07.015_bib0130","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27","author":"Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2460\/javma.232.4.514","article-title":"Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United States","volume":"232","author":"Kasari","year":"2008","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/nar\/12.2.857","article-title":"Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs","volume":"12","author":"Kozak","year":"1984","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/308241a0","article-title":"Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo","volume":"308","author":"Kozak","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0150","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1093\/nar\/15.20.8125","article-title":"An analysis of 5\u2032-noncoding sequences from 699 vertebrate messenger RNAs","volume":"15","author":"Kozak","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)01056-9","article-title":"Pushing the limits of the scanning mechanism for initiation of translation","volume":"299","author":"Kozak","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-5-82","article-title":"Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins","volume":"5","author":"Liu","year":"2008","journal-title":"Virol. J."},{"issue":"7","key":"10.1016\/j.jviromet.2010.07.015_bib0170","doi-asserted-by":"crossref","DOI":"10.4161\/hv.6.7.11761","article-title":"Rift Valley fever virus - an unrecognized emerging threat?","volume":"6","author":"Mandell","year":"2010","journal-title":"Human Vaccines"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"Mandell","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0180","first-page":"183","article-title":"Production of core and virus-like particles with baculovirus infected insect cells","volume":"74","author":"Maranga","year":"2002","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0185","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"The Rift Valley fever epizootic in Egypt 1977\u201378. 1. Description of the epizzotic and virological studies","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0190","first-page":"97","article-title":"Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer","volume":"2","author":"Monie","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0195","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1073\/pnas.1131929100","article-title":"Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection","volume":"100","author":"Murata","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0200","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1016\/j.vaccine.2009.06.019","article-title":"Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells","volume":"27","author":"Nallet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0215","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1128\/JVI.01362-06","article-title":"Generation and analysis of infectious virus-like particles of uukuniemi virus (Bunyaviridae): a useful system for studying bunyaviral packaging and budding","volume":"80","author":"Overby","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0220","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2009.06.020","article-title":"Suspension-Vero cell cultures as a platform for viral vaccine production","volume":"27","author":"Paillet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/088922200309368","article-title":"Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques","volume":"16","author":"Paliard","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0230","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/btpr.187","article-title":"Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system","volume":"25","author":"Pillay","year":"2009","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0235","series-title":"Virus-like Particles as a Vaccine Delivery System: Myths and Facts","author":"Roy","year":"2008"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.virol.2008.02.006","article-title":"Immunization with Toscana virus N-Gc proteins protects mice against virus challenge","volume":"375","author":"Savellini","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000150482","article-title":"Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen","volume":"39","author":"Schirmbeck","year":"1996","journal-title":"Intervirology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0250","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0255","doi-asserted-by":"crossref","DOI":"10.1099\/vir.0.013540-0","article-title":"Functional analysis of the Bunyamwera Orthobunyavirus Gc glycoprotein","author":"Shi","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0260","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/138945007782151360","article-title":"Protein N-glycosylation in the baculovirus-insect cell system","volume":"8","author":"Shi","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0265","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1128\/JVI.00579-06","article-title":"Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis","volume":"80","author":"Shi","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0270","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1128\/JVI.00573-07","article-title":"Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis","volume":"81","author":"Shi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0275","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0280","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/JVI.64.4.1549-1555.1990","article-title":"Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment","volume":"64","author":"Suzich","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0285","series-title":"Infectious Diseases of Livestock with Special Reference to South Africa","article-title":"Rift Valley fever","author":"Swanepoel","year":"2003"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0290","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2987\/08-5791.1","article-title":"Potential for North American mosquitoes to transmit Rift Valley fever virus","volume":"24","author":"Turell","year":"2008","journal-title":"J. Am. Mosq. Control Assoc."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0295","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0300","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BA20050233","article-title":"Bioreactor systems for the production of biopharmaceuticals from animal cells","volume":"45","author":"Warnock","year":"2006","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10616-005-5507-z","article-title":"Cell culture processes for the production of viral vectors for gene therapy purposes","volume":"50","author":"Warnock","year":"2006","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0315","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1128\/JVI.00476-06","article-title":"NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture","volume":"80","author":"Won","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2010.07.015_bib0320","doi-asserted-by":"crossref","first-page":"e9784","DOI":"10.1371\/journal.pone.0009784","article-title":"Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus","volume":"5","author":"Wu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2010.07.015_bib0325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0958-1669(99)80027-5","article-title":"Large-scale transient expression in mammalian cells for recombinant protein production","volume":"10","author":"Wurm","year":"1999","journal-title":"Curr. Opin. Biotechnol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093410002570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093410002570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T11:40:20Z","timestamp":1591530020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093410002570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0166093410002570"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2010.07.015","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}